 need for low-molecular-weight heparin as a
bridge depends on the indication for anticoagulation.
We suggest continuation of beta blocker therapy during the
perioperative period if it is part of an established medical
regimen.
Level of recommendation

2 (Weak)

2 (Weak)

Quality of evidence

B (Moderate)

B (Moderate)

If a decision was made to start beta blocker therapy (because
of the presence of multiple risk factors, such as coronary
arter